Objective: Cardiovascular disease (CVD) contributes significantly to HIV-related morbidity
and mortality. Chronic immune activation and inflammation are thought to augment the …

Determinants of protective immunity against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infection require the development of well-standardized, reproducible …

A patient with B-cell acute lymphoblastic leukemia (ALL) and severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) had persistent, progressive pneumonia with viremia after …

The asymptomatic chronic phase of HIV infection is a dynamic balance between host and
virus, the outcome of which determines an individual's course of disease. Evaluation of the …

Background Persons infected with human immunodeficiency virus (HIV) have increased
rates of coronary artery disease (CAD). The relative contribution of genetic background, HIV-…

Community-level seroprevalence surveys are needed to determine the proportion of the
population with previous SARS-CoV-2 infection, a necessary component of COVID-19 disease …

HIV infection alters the natural history of several cancers, in large part due to its effect on the
immune system. Immune function in people living with HIV may vary from normal to highly …

Herpes zoster (HZ) is a substantial problem for people with decreased cell-mediated immunity,
including older adults. The first vaccine approved for HZ prevention, the zoster vaccine …

Determinants of protective immunity against SARS-CoV-2 infection require the development
of well-standardized, reproducible antibody assays to be utilized in concert with clinical …

Tissue-based T cells are important effectors in the prevention and control of mucosal viral
infections; less is known about tissue-based B cells. We demonstrate that B cells and antibody-…